Prediction of Cancer Treatment Using Advancements in Machine Learning

Area of Science:

• Oncology
• Bioinformatics
• Artificial Intelligence

Background:

• Cancer treatment failure is a major cause of mortality, often due to acquired or intrinsic resistance to chemotherapy and radiation.
• Predicting patient response to cancer therapies remains challenging, influenced by cancer type and genetic factors.
• Current treatment selection lacks robust predictive models, necessitating personalized approaches.

Approach:

• This review explores the application of machine learning (ML), a subset of artificial intelligence (AI), for predicting cancer treatment response.
• It examines the current state of ML algorithms in predicting therapeutic outcomes and overcoming drug resistance.
• The review highlights the challenges in developing clinically useful models due to data limitations, particularly in pharmacogenomics.

Key Points:

• Machine learning models offer a promising avenue for predicting individual patient responses to cancer treatments.
• Accurate prediction models can help personalize therapy selection, improving treatment efficacy and patient outcomes.
• Despite advancements in computing power, the scarcity of comprehensive clinical pharmacogenomics data hinders the development of robust ML models.

Conclusions:

• Machine learning holds significant potential to revolutionize cancer treatment by enabling personalized therapeutic strategies.
• Further research and data collection are crucial for building clinically applicable AI-driven prediction models for cancer therapy.
• Integrating ML into clinical practice could significantly improve outcomes for cancer patients facing treatment resistance.